EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cells with cancer‐associated mutations overtake our tissues as we age

Edward J Evans, James DeGregori

Aging and Cancer · 2021

DOI: 10.1002/aac2.12037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging and Cancer, 2021. Verfasst von Edward J Evans und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BLRD VA, NIA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To shed light on the earliest events in oncogenesis, there is growing interest in understanding the mutational landscapes of normal tissues across ages. In the last decade, next‐generation sequencing of human tissues has revealed a surprising abundance of cells with what would be considered oncogenic mutations.

Aims

We performed a meta‐analysis on previously published sequencing data on normal tissues to categorize mutations based on their presence in cancer and showcase the quantity of cells with cancer‐associated mutations in cancer‐free individuals. Methods and results We analyzed sequencing data from these studies of normal tissues to determine the prevalence of cells with mutations in three different categories across multiple age groups: (1) mutations in genes designated as drivers, (2) mutations that are in the Cancer Gene Census (CGC), and (3) mutations in the CGC that are considered pathogenic. As we age, the percentage of cells in all three levels increase significantly, reaching over 50% of cells having oncogenic mutations for multiple tissues in the older age groups. The clear enrichment for these mutations, particularly at older ages, likely indicates a strong selection for the resulting phenotypes. Combined with an estimation of the number of cells in tissues, we calculate that most older, cancer‐free individuals possess at least 100 billion cells that harbor at least one oncogenic mutation, presumably emanating from a fitness advantage conferred by these mutations that promote clonal expansion.

Conclusions

These studies of normal tissues have highlighted the specific drivers of clonal expansion and how frequently they appear in us. Their high prevalence throughout cancer‐free individuals necessitates a reconsideration of the oncogenicity of these mutations, which could shape methods of detection, prevention, and treatment of cancer, as well as of the potential impact of these mutations on tissue function and our health.

Schlagwörter

Stichwörter der Autor:innen

cancer evolutionlife history theorymutational landscapesomatic evolution

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • University of Colorado Comprehensive Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Förderung

  • BLRD VA
  • NIA NIH HHS
  • NCI NIH HHS

Zitieren

APA

Evans, E. J., & DeGregori, J. (2021). Cells with cancer‐associated mutations overtake our tissues as we age. Aging and Cancer. https://doi.org/10.1002/aac2.12037

Vancouver

Evans EJ, DeGregori J. Cells with cancer‐associated mutations overtake our tissues as we age. Aging and Cancer. 2021. doi:10.1002/aac2.12037

BibTeX
@article{Evans2021,
  author = {Evans, Edward J and DeGregori, James},
  title = {Cells with cancer‐associated mutations overtake our tissues as we age},
  journal = {Aging and Cancer},
  year = {2021},
  doi = {10.1002/aac2.12037}
}
Kostenlos starten →